Description
WHAT IS LIPPOD (LIPOSOMAL DOXORUBICIN HCL) 20ML/10ML?
LIPPOD (LIPOSOMAL DOXORUBICIN HCL) 20ML/10ML is a liposomal formulation of doxorubicin, a powerful chemotherapy agent. The liposome technology allows the drug to reach tumors more precisely while reducing damage to healthy tissues.
HOW IT WORKS
Doxorubicin interferes with cancer cell DNA, stopping their growth and replication. The liposomal coating helps it circulate longer in the bloodstream, targeting tumors more effectively. This reduces side effects, especially on the heart and skin.
WHEN TO USE IT
Doctors prescribe LIPPOD (LIPOSOMAL DOXORUBICIN HCL) or:
-
Advanced ovarian cancer
-
Metastatic breast cancer
-
Kaposi’s sarcoma in HIV patients
It may also be used in blood cancers and off-label settings when standard chemotherapy causes severe reactions.
HOW TO ADMINISTER IT
A trained oncology team gives this medicine by slow intravenous infusion. The dose depends on your body weight, cancer type, and overall health. The treatment usually follows cycles, with rest periods in between.
STORAGE AND HANDLING
Keep the vials refrigerated at 2°C–8°C. Do not freeze. Allow the product to reach room temperature before administration. Avoid shaking. Discard any unused solution after opening.
WHY LIPPOD (LIPOSOMAL DOXORUBICIN HCL) 20ML/10ML IS PREFERRED
This formulation improves drug delivery and limits exposure to non-cancerous tissues. Patients often experience fewer side effects like hair loss, heart damage, or skin burns compared to conventional doxorubicin.
BALANCED EFFECTIVENESS AND SAFETY
LIPPOD allows for effective cancer control while supporting a better quality of life during treatment. It’s especially useful in patients with existing health issues or those who previously struggled with standard chemotherapy.
USED WORLDWIDE IN MODERN CANCER CARE
Trusted in oncology centers globally, this medication plays a key role in treating aggressive cancers with more precision and fewer long-term risks.
